Search research articles
Contact Us
Filters
Showing results (111-120 of 541) with videos related to
Page
of 55
Sort By:
Journal of Clinical Immunology
|
June 15, 2013
Prioritization of evidence-based indications for intravenous immunoglobulin
Jordan S Orange, Hans D Ochs, Charlotte Cunningham-Rundles
The Journal of Allergy and Clinical Immunology
|
September 5, 2013
Coding-region alterations in BTK do not universally cause X-linked agammaglobulinemia
Jordan K Abbott, Hans D Ochs, Erwin W Gelfand
The Journal of Allergy and Clinical Immunology
|
April 2, 2013
Controversies in IgG replacement therapy in patients with antibody deficiency diseases
Erwin W Gelfand, Hans D Ochs, William T Shearer
Therapeutics and Clinical Risk Management
|
February 20, 2010
Subcutaneous immunoglobulin replacement therapy in the treatment of patients with primary immunodeficiency disease
Suzanne Skoda-Smith, Troy R Torgerson, Hans D Ochs
Lancet (London, England)
|
February 23, 1974
Letter: Liver disease and immunodeficiency syndromes
I T Thomas, H D Ochs, R J Wedgwood
Current Opinion in Hematology
|
January 1, 1994
The molecular basis of X-linked agammaglobulinemia, hyper-IgM syndrome, and severe combined immunodeficiency in humans
A Aruffo, D Hollenbaugh, L H Wu, et al.
FEBS Letters
|
September 15, 2001
Bruton's tyrosine kinase is a substrate of calpain in human platelets
S Mukhopadhyay, A S Ramars, H D Ochs, et al.
Blood
|
August 1, 1990
Origin of mutations in two families with X-linked chronic granulomatous disease
U Francke, H D Ochs, B T Darras, et al.
Clinical and Experimental Immunology
|
March 19, 2011
Efficacy and safety of home-based subcutaneous immunoglobulin replacement therapy in paediatric patients with primary immunodeficiencies
M Borte, E Bernatowska, H D Ochs, et al.
Fertility and Sterility
|
November 1, 1986
Undetected ovulation in in vitro fertilization-embryo transfer patients
D P Wolf, D Ochs, S Nader, et al.
Page
of 55
Search research articles
Search
Showing results (111-120 of 541) with videos related to
Sort By:
Page
of 55
Journal of Clinical Immunology
|
June 15, 2013
Prioritization of evidence-based indications for intravenous immunoglobulin
Jordan S Orange, Hans D Ochs, Charlotte Cunningham-Rundles
The Journal of Allergy and Clinical Immunology
|
September 5, 2013
Coding-region alterations in BTK do not universally cause X-linked agammaglobulinemia
Jordan K Abbott, Hans D Ochs, Erwin W Gelfand
The Journal of Allergy and Clinical Immunology
|
April 2, 2013
Controversies in IgG replacement therapy in patients with antibody deficiency diseases
Erwin W Gelfand, Hans D Ochs, William T Shearer
Therapeutics and Clinical Risk Management
|
February 20, 2010
Subcutaneous immunoglobulin replacement therapy in the treatment of patients with primary immunodeficiency disease
Suzanne Skoda-Smith, Troy R Torgerson, Hans D Ochs
Lancet (London, England)
|
February 23, 1974
Letter: Liver disease and immunodeficiency syndromes
I T Thomas, H D Ochs, R J Wedgwood
Current Opinion in Hematology
|
January 1, 1994
The molecular basis of X-linked agammaglobulinemia, hyper-IgM syndrome, and severe combined immunodeficiency in humans
A Aruffo, D Hollenbaugh, L H Wu, et al.
FEBS Letters
|
September 15, 2001
Bruton's tyrosine kinase is a substrate of calpain in human platelets
S Mukhopadhyay, A S Ramars, H D Ochs, et al.
Blood
|
August 1, 1990
Origin of mutations in two families with X-linked chronic granulomatous disease
U Francke, H D Ochs, B T Darras, et al.
Clinical and Experimental Immunology
|
March 19, 2011
Efficacy and safety of home-based subcutaneous immunoglobulin replacement therapy in paediatric patients with primary immunodeficiencies
M Borte, E Bernatowska, H D Ochs, et al.
Fertility and Sterility
|
November 1, 1986
Undetected ovulation in in vitro fertilization-embryo transfer patients
D P Wolf, D Ochs, S Nader, et al.
Page
of 55